Functional CD5+ B cells develop predominantly in the spleen of NOD/SCID/γcnull (NOG) mice transplanted either with human umbilical cord blood, bone marrow, or mobilized peripheral blood CD34+ cells

This publication has 27 references indexed in Scilit:

• CXCL13 Is Required for B1 Cell Homing, Natural Antibody Production, and Body Cavity Immunity
  Immunity, 2002
• Arrested B Lymphopoiesis and Persistence of Activated B Cells in Adult Interleukin 7−/− Mice
  The Journal of Experimental Medicine, 2001
• An Essential Role for BAFF in the Normal Development of B Cells Through a BCMA-Independent Pathway
  Science, 2001
• Similar myeloid recovery despite superior overall engraftment in NOD/SCID mice after transplantation of human CD34+ cells from umbilical cord blood as compared to adult sources
  Bone Marrow Transplantation, 2001
• Analysis of immune reconstitution in children undergoing cord blood transplantation
  Experimental Hematology, 2001
• Expansion of human NOD/SCID-repopulating cells by stem cell factor, Flk2/Flt3 ligand, thrombopoietin, IL-6, and soluble IL-6 receptor
  Journal of Clinical Investigation, 2000
• Human Hematopoietic Stem/Progenitor Cells Generate CD5⁺B Lymphoid Cells in NOD/SCID Mice
  The International Journal of Cell Cloning, 1999
• A rapid and non‐invasive selection of transgenic embryos before implantation using green fluorescent protein (GFP)
  FEBS Letters, 1995
• Origin of Murine B Cell Lineages
  Annual Review of Immunology, 1993
• The ontogeny and functional characteristics of human B-1 (CD5⁺ B) cells
  International Immunology, 1992